Clinical Trials Sponsored by Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale

Total 208 results

Istituto Nazionale Tumori IRCCS - Fondazione G....

Unknown

A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma (LEBEN)

Recurrent Adult Hodgkin Lymphoma

Italy
European Institute of Oncology
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale

Recruiting

Intervention Study in Prostate Cancer Patients Undergoing Radiotherapy (MicroStyle)

Prostate Cancer

Italy
Regina Elena Cancer Institute
Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale

Completed

EXPERIMENTAL STUDY A.R.C.O. (CANCER CAREGIVER REMOTE ASSISTANCE)TELEHEALTH HOME MEDICATION VS/OUTPATIENT MEDICATION OF CENTRAL VENOUS CATHETER PICC (PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER) (ARCO)

Infections

Italy
Fondazione Policlinico Universitario Agostino Gemelli...
Istituti Fisioterapici Ospitalieri; Istituto Nazionale Tumori IRCCS - Fondazione...

Not yet recruiting

Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA) (MIMOSA)

Diffuse Large B Cell Lymphoma | Relapsed Non-Hodgkin Lymphoma

Italy
European Institute of Oncology
Istituto Oncologico Veneto IRCCS; Ente Ospedaliero Ospedali Galliera; Istituto...

Not yet recruiting

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion (TOLERANT)

Ductal Carcinoma in Situ | RAD51C Gene Mutation | RAD51D Gene Mutation | PALB2 Gene Mutation | Lobular Carcinoma in Situ | ATM Gene Mutation | CDH1 Gene Mutation | CHEK2 Gene Mutation | BRCA Mutation

Italy
Regina Elena Cancer Institute
Centro di Riferimento Oncologico - Aviano; Fondazione Salvatore Maugeri; Istituti... and other collaborators

Recruiting

PRO Survivorship Concerns ITA (PRO)

Quality of Life | Psychological Distress | Breast Neoplasm Female

Italy
Azienda Unità Sanitaria Locale Reggio Emilia
Istituto Di Ricerche Farmacologiche Mario Negri; Istituto Nazionale Tumori...

Recruiting

Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB (LIBImAb)

Metastatic Colorectal Cancer | Colorectal Cancer | RAS Mutation

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Study of PembrolizumAb combiNeD With Cisplatin or carbOplatin and Etoposide in Treatment naïve Advanced meRkel Cell cArcinoma (MCC) (PANDORA)

Merkel Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Patient-tailored Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases (OrganoHIPEC) (OrganoHIPEC)

Peritoneal Metastases From Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Mini-invasive Detection of Residual Disease in Breast Cancer Patients in Remission After Primary Chemotherapy

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Treatments of HPV-related Lesions

Cervical Cancer | HPV | Cervix Lesion | Vagina Disease
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Indocyanine Green-guided Lymphadenectomy in Laparoscopic Total Mesorectal Excision for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy ((GreenEye-CRC))

Rectal Cancer | Lymph Node Cancer Metastatic

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy (Serpentine)

Melanoma | Renal Cell Carcinoma | Breast Cancer | NSCLC | Urinary Bladder Cancer | Squamous Cell Carcinoma of Head and Neck | Small Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients (ACAPP)

Pseudomyxoma Peritonei

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

TSH Suppression During Radiotherapy on Thyroid Site to Prevent Iatrogenic Hypothyroidism in Pediatric Cancer Patients (WIN-HYPO2021)

Hypothyroidism; Irradiation

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Peritoneal Lavage Liquid Biopsy in Patients With Gastric Cancer (LIQUID)

Gastric Cancer | Gastric Adenocarcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) (Style)

Thymic Carcinoma | Type B3 Thymoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers (ARMANI)

Stomach Neoplasms

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Activity of Sorafenib in Salivary Gland Cancer

Salivary Gland Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

Post Operative Pain | Hyperalgesia

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Enrolling by invitation

Gene Expression Profile of Resected Pancreatic and Ampullary Adenocarcinoma at Favorable Prognosis

Resectable Pancreatic Adenocarcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention (DietINT)

Cancer of Head and Neck

Austria, Slovenia, Germany, Italy, Poland, Portugal
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer (MAYA)

Metastatic Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

The TI.VA Algorithm: A First-in-Humans Test. (TIVAly)

Anesthesia

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas (RAF)

Retroperitoneal Sarcoma | Intraoperative Hypotension | Adrenal; Functional Disturbance

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Active, not recruiting

Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs (MetNET1)

Well Differentiated Pancreatic Endocrine Tumor

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Wound Infections in Breast Cancer Surgery After Preoperative Skin Preparation With Chlorhexidine vs. Povidone-iodine

Breast Neoplasms | Wound Infection

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

A Comparison Between TOF Watch® SX and Tetragraph®

Neuromuscular Blockade | Neuromuscular Monitoring

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Active, not recruiting

Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors. (PEOPLE)

Non Small Cell Lung Cancer (NSCLC)

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Active, not recruiting

The MetNET-2 Trial (MetNET-2)

Neuroendocrine Tumors

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

A Study of CaBozantinib in Patients With Advanced or Unresectable Renal cEll cArcinoma (BREAKPOINT)

Metastatic Renal Cell Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

A Phase II Study Evaluating the Efficacy of Enzalutamide and the Role of ARv7 in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients With Visceral Disease. (EXCALIBUR)

Carcinoma Prostate

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer (SLN_EC)

Endometrial Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 (SGC-AX14)

Salivary Gland Cancers

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer (MITO27)

Ovarian Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer (MICROLEARNER)

Head and Neck Cancer | Prostate Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) (AFP-UTS)

Liver Transplantation | HCC | Mortality | Cancer Recurrence | Alphafetoprotein | Competing Risk | Selection Criteria
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast (DCIS)

Carcinoma Breast

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer

Malnutrition | Gastrointestinal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

NAC Sparing Mastectomy After Neo-adjuvant Chemotherapy

Breast Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel

Nausea | Vomiting

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors

Testicular Neoplasms | Germ Cell Tumors

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma (PTCL-06)

Lymphoma, T-Cell, Peripheral

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Unknown

Colorectal Cancer Detection by Means of Optical Fluoroscopy

Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Not yet recruiting

Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project (Eternity)

Cervical Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Adjuvant Pressurized Intraperitoneal Aerosol Chemotherapy to Prevent Colorectal Peritoneal Metastases (ProphyPIPAC) (ProphyPIPAC)

Peritoneal Metastases From Colorectal Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

A Retrospective Study on Multiple Classifier Endometrial Cancer

Uterine Cancer

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

The ImmunoXXL Study (ImmunoXXL)

Hepatocellular Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Metastatic Clear Cell Renal Carcinoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients (Agility)

Melanoma

Italy

Clinical Trials Sponsored by Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations